Medical Stocks

C.R. Bard Inc. Valuation – November 2015 Update $BCR

C.R. Bard Inc. qualifies for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio and the high PEmg and PB ratios. The Enterprising Investor is only initially concerned with the level of debt relative to the net current assets.

Read More
Feature Industry Review

The Best Companies of the Medical Industry – June 2015

While ModernGraham supports the bottom-up approach to investing, many investors do utilize the top-down method, whereby an industry is selected before the company itself. With that in mind, this article will take a brief look at the best companies of the medical industry, selecting the most promising investment opportunities within the industry, and giving a broad look into the industry as a whole.

Read More
Feature Value Investing Weekly

47 Companies in the Spotlight This Week – 5/16/15

We evaluated 47 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

Read More
Feature Value Investing Weekly

13 Companies in the Spotlight This Week – 10/4/14

We evaluated 17 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic […]

Read More
Back To Top